1,676 reports of this reaction
3.3% of all ANASTROZOLE TABLETS reports
#3 most reported adverse reaction
DIARRHOEA is the #3 most commonly reported adverse reaction for ANASTROZOLE TABLETS, manufactured by Avet Pharmaceuticals Inc. There are 1,676 FDA adverse event reports linking ANASTROZOLE TABLETS to DIARRHOEA. This represents approximately 3.3% of all 50,885 adverse event reports for this drug.
Patients taking ANASTROZOLE TABLETS who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among ANASTROZOLE TABLETS users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for ANASTROZOLE TABLETS:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 1,676 FDA reports for ANASTROZOLE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.3% of all adverse event reports for ANASTROZOLE TABLETS, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking ANASTROZOLE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.